share_log

Insiders Buy Around $2M Of 2 Penny Stocks

Insiders Buy Around $2M Of 2 Penny Stocks

内部人士购买价值约200万美元的2便士股票
Benzinga Real-time News ·  2022/05/26 08:06


US stock futures traded higher on Thursday, with the Dow futures adding more than 200 points this morning. Investors, meanwhile, focused on some notable insider trades.


周四,美国股指期货走高,道琼斯指数今天上午上涨了200多点。与此同时,投资者关注的是一些值得注意的内幕交易。

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

当内部人士买卖股票时,这表明了他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易员可以在他们的整体投资或交易决策中考虑这一因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

以下是最近几笔值得注意的细价股内幕交易。有关更多信息,请查看Benzinga的内幕交易平台。

Nocopi Technologies

Nocopi技术公司

The Trade: Nocopi Technologies, Inc. (OTC:NNUP) 10% owner Michael Liebowitz acquired a total of 9,175,927 shares at an average price of $0.17. To acquire these shares, it cost $1.55 million.

行业: Nocopi技术公司(场外交易代码:NNUP)10%的股东Michael Liebowitz以0.17美元的平均价格收购了总计9,175,927股股票。收购这些股份的成本为155万美元。

What's Happening: Nocopi Technologies recently announced results for its first quarter ended March 31, 2022.

正在发生的事情:Nocopi Technologies最近公布了截至2022年3月31日的第一季度业绩。

What Nocopi Technologies Does: Nocopi Technologies Inc develops and markets specialty reactive inks. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the entertainment and toy and the document and product authentication markets in the United States and foreign countries.

Nocopi Technologies做了什么:Nocopi Technologies Inc.开发和销售特种活性油墨。其主要业务是开发和分销文件安全产品,并为娱乐和玩具以及美国和其他国家的文件和产品认证市场授权其专利活性墨水技术。

Second Sight Medical Products

第二视觉医疗产品

The Trade: Second Sight Medical Products, Inc. (NASDAQ:EYES) Director Gregg Williams acquired a total of 222,598 shares at an average price of $1.97. The insider spent around $438.6 thousand to buy those shares.

《贸易》: 第二视界医疗产品有限公司。(纳斯达克股票代码:Eyes)董事格雷格·威廉姆斯以1.97美元的平均价格收购了222,598股票。这位内部人士花了大约43.86万美元购买了这些股票。

What's Happening: Second Sight Medical was recently granted a Notice of Allowance for U.S. patent titled 'Face Detection Tracking And Recognition For A Visual Prosthesis.'

发生了什么事?:第二视力医疗公司最近获得了一项美国专利的补贴通知,该专利名为“用于视觉假体的人脸检测跟踪和识别”。

What Second Sight Medical Products Does: Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals.

第二视觉医疗产品的作用是什么:Second Sight医疗产品公司开发、制造和销售可植入的假体设备,为盲人创造一种有用的人工视力形式。

Also check this: Home Depot And 2 Other Stocks Insiders Are Buying

再看看这个:家得宝和其他两只股票的内部人士正在买入

Don't forget to check out our premarket coverage here .

别忘了在这里查看我们的售前报道。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发